Clinical Toxicology 2006
Double staining of TGF-2 and p-c-MET allowed the classification of the tumor specimens into four groups (Fig
But a recent systematic review and meta-analysis conducted to inform international PCOS guideline updates concluded that the evidence supporting inositol for PCOS is limited and inconclusive.17 That doesnt mean it cant help it means outcomes arent predictable, and it shouldnt be positioned as a reliable stand-alone solution
In sum, while mechanistic plausibility is strong and extrapolation from prostate oncology supports the concept of therapeuticwindow expansion, there is presently no highlevel randomized evidence in cervical/gynecologic oncology showing hydrogels expand the therapeutic window (i.e., allowing higher tumor dose or less toxicity at equivalent tumor dose)
Semaglutide (Wegovy/Ozempic) works on GLP-1 alone
You can read the abstract of this article at LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial PubMed (nih.gov)
